Stay updated on Pediatric Tesevatinib Safety in ARPKD Clinical Trial
Sign up to get notified when there's something new on the Pediatric Tesevatinib Safety in ARPKD Clinical Trial page.

Latest updates to the Pediatric Tesevatinib Safety in ARPKD Clinical Trial page
- CheckyesterdayChange DetectedAdded revision entry v3.5.0 and removed revision v3.4.3 from the history log.SummaryDifference0.1%

- Check8 days agoChange DetectedRecord History now shows a new revision entry v3.4.3. The previous revision v3.4.2 has been removed from the list.SummaryDifference0.1%

- Check15 days agoNo Change Detected
- Check22 days agoNo Change Detected
- Check37 days agoChange DetectedA new revision entry (v3.4.2) was added to the record history, while older notices about funding and revision v3.4.1 were removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.8%

- Check44 days agoChange DetectedA site-wide notice about government funding and a revision update to v3.4.1 were added, replacing the previous v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.8%

- Check51 days agoChange DetectedThe Record History page introduces a 'Show glossary' option, color-coded indicators for changes, and updates the revision label to v3.4.0 (from v3.3.4).SummaryDifference1%

- Check87 days agoChange DetectedThe history page now includes Revision: v3.3.3, and the footer no longer lists HHS Vulnerability Disclosure or Revision: v3.3.2.SummaryDifference0.2%

Stay in the know with updates to Pediatric Tesevatinib Safety in ARPKD Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pediatric Tesevatinib Safety in ARPKD Clinical Trial page.